Zaleplon (Compound)

Synonyms:zaleplon, 151319-34-5, Sonata, CL-284846, SKP-1041, ZAL-846, CL 284,846, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide, LJC 10846, L846, CL 284846, LJC-10846, L-846, DEA No. 2781, Zaleplon civ, 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide, N-(3-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide, S62U433RMH, DTXSID5023748, CHEBI:10102, N-(3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide, NCGC00160525-01, DTXCID103748, ZAL 846, N-(3-{3-cyanopyrazolo[1,5-a]pyrimidin-7-yl}phenyl)-N-ethylacetamide, Staccato-zaleplon, SMR000238180, Sonata (TN), CAS-151319-34-5, UNII-S62U433RMH, Zaleplon AP, Zaleplon [USAN:USP:INN:BAN], 3'-(3-Cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide, AZ-007, ZALEPLON [USAN], ZALEPLON [INN], ZALEPLON [JAN], ZALEPLON [MI], ZALEPLON [VANDF], ZALEPLON [MART.], ZALEPLON [WHO-DD], Acetamide, N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethyl-, Zaleplon (JAN/USP/INN), CHEMBL1521, ZALEPLON [EMA EPAR], SCHEMBL29118, MLS000759451, MLS001424238, BIDD:GT0046, ZALEPLON [ORANGE BOOK], ZALEPLON CIV [USP-RS], GTPL4345, ZALEPLON [USP MONOGRAPH], BDBM86521, Zaleplon 1.0 mg/ml in Methanol, HMS2052J11, HMS3394J11, HMS3713H08, ACT04427, BCP21340, CAS_5719, NSC_5719, Tox21_111872, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-acetamide, Zaleplon, >=98% (HPLC), solid, Acetamide, N-(3-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)phenyl)-N-ethyl-, AKOS000280863, Tox21_111872_1, AC-2082, CCG-101187, DB00962, NC00437, SS-4571, NCGC00160525-02, HY-14265, DB-015068, A12993, C07484, D00530, AB00640003_03, A809159, Q145052, SR-01000759426, SR-01000759426-3, Zaleplon, United States Pharmacopeia (USP) Reference Standard, N-[3-(Cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide, 3'-(3-CYANOPYRAZOLO(1,5-.ALPHA.)PYRIMIDIN-7-YL)-N-ETHYLACETANILIDE, N-[3-(3-cyanopyrazolo-[1,5-a]-pyrimidin-7-yl)-phenyl]-N-ethyl acetamide, ACETAMIDE, N-(3-(3-CYANOPYRAZOLO(1,5-.ALPHA.)PYRIMIDIN-7-YL)PHENYL)-N-ETHYL-, 1007130-22-4

Pubchem:PUBCHEM:5719

Id:bdf929d2-1222-5755-a7b8-58f2d55fe88d

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Zaleplon's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Zaleplon.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Zaleplon.

Results found

Linked to

	Label	Description
	BRD-K92657060-001-05-7 Substance (Entity type)	A Substance
	zaleplon (ad88781e-b2de-42c7-b2d4-81bdb9830c92) Collection (Entity type)	Metadatata for zaleplon
	DCSTRUCT ID 02857 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02857; PubChem_CID:5719, FILE=drugcentral_drug_02857.json)
	Zaleplon negatively regulates ST6GALNAC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zaleplon negatively regulates ANXA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zaleplon negatively regulates CD9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zaleplon positively regulates RUFY3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zaleplon positively regulates HSPA8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zaleplon negatively regulates STEAP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Zaleplon positively regulates CDC7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS